Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2022

Sep 15, 2022

30561_dirs_2022-09-14_b5eed681-3bed-49b3-ad37-11fb36746886.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2022-09-12

Reporting Person: Haley Patrick J. (EVP, Commercial)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-09-12 Common Stock M 40000 $6.21 Acquired 301591 Direct
2022-09-12 Common Stock S 40000 $17.94 Disposed 261591 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-09-12 Option (right to buy) $6.21 M 40000 Disposed 2022-09-15 Common Stock (40000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23539 Indirect
Common Stock 10648 Indirect

Footnotes

F1: Includes 166,341 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022.

F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.67 to $18.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

F4: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 9, 2022.

F5: The option, representing the right to purchase a total of 60,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019.